Mark E. Astill

791 total citations
18 papers, 343 citations indexed

About

Mark E. Astill is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Neurology. According to data from OpenAlex, Mark E. Astill has authored 18 papers receiving a total of 343 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 5 papers in Radiology, Nuclear Medicine and Imaging and 4 papers in Neurology. Recurrent topics in Mark E. Astill's work include Monoclonal and Polyclonal Antibodies Research (5 papers), Myasthenia Gravis and Thymoma (4 papers) and HER2/EGFR in Cancer Research (3 papers). Mark E. Astill is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (5 papers), Myasthenia Gravis and Thymoma (4 papers) and HER2/EGFR in Cancer Research (3 papers). Mark E. Astill collaborates with scholars based in United States. Mark E. Astill's co-authors include Harry R. Hill, James T. Wu, Jerry W. Pickering, M. Carl Schroder, Stephen W. Hildreth, Thomas B. Martins, Christine M. Litwin, Robert A. Stephenson, Ping Zhang and Bradley W. Lyons and has published in prestigious journals such as Scientific Reports, Antimicrobial Agents and Chemotherapy and Clinical Chemistry.

In The Last Decade

Mark E. Astill

16 papers receiving 331 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark E. Astill United States 9 119 108 82 72 65 18 343
Kou Uchida Japan 10 73 0.6× 63 0.6× 23 0.3× 51 0.7× 45 0.7× 27 329
Fidan Jmor United Kingdom 9 79 0.7× 63 0.6× 33 0.4× 78 1.1× 21 0.3× 9 320
Thabo Lapp Germany 14 103 0.9× 99 0.9× 279 3.4× 54 0.8× 21 0.3× 55 665
H.B. Armah Ghana 7 78 0.7× 53 0.5× 17 0.2× 71 1.0× 53 0.8× 10 405
Maja Neiman Sweden 10 136 1.1× 25 0.2× 76 0.9× 12 0.2× 22 0.3× 11 269
Michael Winkelmann Germany 8 40 0.3× 51 0.5× 45 0.5× 126 1.8× 40 0.6× 38 372
Silvia Campo Italy 8 79 0.7× 71 0.7× 23 0.3× 36 0.5× 26 0.4× 12 382
Julia Riegger Germany 4 220 1.8× 166 1.5× 21 0.3× 25 0.3× 113 1.7× 5 451
Matthew P. Mulè United States 10 196 1.6× 79 0.7× 15 0.2× 105 1.5× 21 0.3× 14 521
Anouk C. M. Platteel Netherlands 10 132 1.1× 127 1.2× 19 0.2× 34 0.5× 24 0.4× 14 348

Countries citing papers authored by Mark E. Astill

Since Specialization
Citations

This map shows the geographic impact of Mark E. Astill's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark E. Astill with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark E. Astill more than expected).

Fields of papers citing papers by Mark E. Astill

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark E. Astill. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark E. Astill. The network helps show where Mark E. Astill may publish in the future.

Co-authorship network of co-authors of Mark E. Astill

This figure shows the co-authorship network connecting the top 25 collaborators of Mark E. Astill. A scholar is included among the top collaborators of Mark E. Astill based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark E. Astill. Mark E. Astill is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Phạm, Hà, et al.. (2022). eP386: Cystic fibrosis 165 pathogenic variants genotyping by MassARRAY. Genetics in Medicine. 24(3). S243–S244.
2.
Redecke, Vanessa, Kazuki Tawaratsumida, Erin T. Larragoite, et al.. (2021). A rapid and affordable point of care test for antibodies against SARS-CoV-2 based on hemagglutination and artificial intelligence interpretation. Scientific Reports. 11(1). 24507–24507. 7 indexed citations
3.
Astill, Mark E., et al.. (2015). Detection of Acetylcholine Receptor Modulating Antibodies by Flow Cytometry. American Journal of Clinical Pathology. 143(2). 186–192. 21 indexed citations
4.
Pickering, Jerry W., et al.. (2007). A 22-plex Chemiluminescent Microarray for Pneumococcal Antibodies. American Journal of Clinical Pathology. 128(1). 23–31. 20 indexed citations
5.
Pickering, Jerry W., Thomas B. Martins, M. Carl Schroder, et al.. (2002). A Multiplexed Fluorescent Microsphere Immunoassay for Antibodies to Pneumococcal Capsular Polysaccharides. American Journal of Clinical Pathology. 117(4). 589–596. 135 indexed citations
6.
Astill, Mark E., et al.. (1998). Serum chromogranin A: Early detection of hormonal resistance in prostate cancer patients. Journal of Clinical Laboratory Analysis. 12(1). 20–25. 40 indexed citations
7.
Herron, James N., et al.. (1998). <title>Rapid clinical diagnostics assays using injection-molded planar waveguides</title>. Proceedings of SPIE, the International Society for Optical Engineering/Proceedings of SPIE. 3259. 54–64. 3 indexed citations
8.
Lyons, Bradley W., Lily Wu, Mark E. Astill, & James T. Wu. (1998). Development of an assay for modulating anti‐acetylcholine receptor autoantibodies using human rhabdomyosarcoma cell line. Journal of Clinical Laboratory Analysis. 12(5). 315–319.
9.
Lyons, Bradley W., Lily Wu, Mark E. Astill, & James T. Wu. (1998). Development of an assay for modulating anti-acetylcholine receptor autoantibodies using human rhabdomyosarcoma cell line. Journal of Clinical Laboratory Analysis. 12(5). 315–319. 8 indexed citations
10.
Wu, James T., Ping Zhang, Mark E. Astill, et al.. (1995). Psa immunoreactivity detected in lncap cell medium, breast tumor cytosol, and female serum. Journal of Clinical Laboratory Analysis. 9(4). 243–251. 11 indexed citations
11.
Zhang, Ping, et al.. (1995). Evaluation of free psa isoforms, psa complex formation, and specificity of anti‐psa antibodies by hplc and page‐immunoblotting techniques. Journal of Clinical Laboratory Analysis. 9(1). 1–14. 14 indexed citations
12.
13.
Wu, James T., Ping Zhang, Mark E. Astill, Bradley W. Lyons, & Lily Wu. (1995). Identification and characterization of c‐erbb‐2 proteins in serum, breast tumor tissue, and sk‐br‐3 cell line. Journal of Clinical Laboratory Analysis. 9(3). 141–150. 13 indexed citations
14.
Wu, James T., et al.. (1995). Purification of psa‐act complex: Characterization of psa‐act complex by various chromatographic procedures. Journal of Clinical Laboratory Analysis. 9(1). 25–31. 7 indexed citations
15.
Wu, James T., Mark E. Astill, Christopher Lloyd, & Valérie Salmon. (1993). Rhabdomyosarcoma cell line can be used for the isolation of soluble acetylcholine receptor and for assaying blocking and modulating autoantibodies. Journal of Clinical Laboratory Analysis. 7(1). 11–18. 7 indexed citations
16.
Wu, James T., Mark E. Astill, & Ping Zhang. (1993). Detection of the extracellular domain of c‐erbB‐2 oncoprotein in sera from patients with various carcinomas: Correlation with tumor markers. Journal of Clinical Laboratory Analysis. 7(1). 31–40. 28 indexed citations
17.
18.
White, John S., et al.. (1979). Effect of Cephapirin on Formation of d -Alanine Carboxypeptidase in Growing Bacillus subtilis Cells. Antimicrobial Agents and Chemotherapy. 15(2). 204–208. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kou Uchida Breakdown of academic impact, for papers by Fidan Jmor Breakdown of academic impact, for papers by Thabo Lapp Breakdown of academic impact, for papers by H.B. Armah Breakdown of academic impact, for papers by Maja Neiman Breakdown of academic impact, for papers by Michael Winkelmann Breakdown of academic impact, for papers by Silvia Campo Breakdown of academic impact, for papers by Julia Riegger Breakdown of academic impact, for papers by Matthew P. Mulè Breakdown of academic impact, for papers by Anouk C. M. Platteel
Rankless by CCL
2026